throbber
Case 2:17-cv-03159-ES-MAH Document 16 Filed 06/27/17 Page 1 of 4 PageID: 295
`
`Charles M. Lizza
`William C. Baton
`
`--
`
`Ii.ThIIThcLIJZP
`
`One Riverfront Plaza, Suite 1520
`Newark, NJ 07 102-5426
`(973) 286-6700
`clizza@saul.com
`
`Attorneysfor Plaintff
`Celgene Corporation
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`CELGENE CORPORATION,
`
`Plaintiff,
`
`Civil Action No. 17-3159 (ES)(JAD)
`
`(Filed Electronically)
`
`PAR PHARMACEUTICAL, INC., PAR
`PHARMACEUTICAL COMPANIES, INC.,
`TEVA PHARMACEUTICALS USA, INC.,
`and TEVA PHARMACEUTICAL
`INDUSTRIES LIMITED,
`
`Defendants.
`
`STIPULATION DISMISSING TEVA PHARMACEUTICAL INDUSTRIES LTD.
`
`Plaintiff Celgene Corporation (“Celgene”) and Defendants Teva Pharmaceuticals USA,
`
`Inc. (“Teva USA”) and Teva Pharmaceutical Industries Limited (“Teva Ltd.”) hereby stipulate,
`
`subject to approval of the Court, to dismiss the Complaint filed by Plaintiff against Teva Ltd. in
`
`the above-captioned action (“Action,” defined to include this action, any action that may result
`
`from case consolidation, or any lead case with which this action is associated). The Action will
`
`continue against Teva USA. It is further stipulated that this dismissal is without prejudice and is
`
`subject to the following conditions:
`
`

`

`Case 2:17-cv-03159-ES-MAH Document 16 Filed 06/27/17 Page 2 of 4 PageID: 296
`
`1.
`
`2.
`
`Teva Ltd. agrees to be bound by any Judgment, Order, or decision in this Action,
`
`Teva USA will answer or otherwise respond to the Complaint in this Action on or
`
`before August 7, 2017.
`
`3.
`
`Teva Ltd. and Teva USA stipulate that Teva Ltd.’s documents, witnesses, and
`
`information are in Teva USA’ s custody or control for purposes of discovery or requests for
`
`admission in this lawsuit, subject to Paragraph 4. To be clear, Teva Ltd. agrees that it will search
`
`for and provide discovery in response to discovery requests served on Teva USA in the Action as
`
`if the discovery were Teva USA’s own.
`
`4.
`
`If the parties agree that a Teva Ltd. employee is a necessary fact witness, the
`
`witness will be made available for deposition (at or near the witness’s work location) upon notice
`
`to Teva USA. Accordingly, there will be no need for (a) service of subpoenas; or (b) for
`
`witnesses located outside the United States, adherence to the procedures of the Hague
`
`Convention or other methods of foreign service. If the parties disagree as to whether the Teva
`
`Ltd. employee is a necessary fact witness, then the parties shall present the matter to the Court
`
`for resolution.
`
`In the event that the Court orders that the deposition of the Teva Ltd. employee
`
`shall be taken, then the Teva Ltd. employee will be made available for deposition (at or near the
`
`witness’s work location) pursuant to the Court’s Order, without requiring Plaintiffs to adhere to
`
`the procedures of the Hague Convention. Teva USA will also accept Fed. R. Civ. P. 30(b)(6)
`
`deposition notices containing topics directed to information that may be held by Teva Ltd., and
`
`any witness presented in response thereto shall investigate information in the possession,
`
`custody, or control of Teva Ltd. as necessary. Teva Ltd. further agrees to be bound by the
`
`resolution of discovery matters in this Action.
`
`2
`
`

`

`Case 2:17-cv-03159-ES-MAH Document 16 Filed 06/27/17 Page 3 of 4 PageID: 297
`
`5.
`
`Teva USA and Teva Ltd. agree that, for purposes of this Action only, they will
`
`such, will not move to dismiss the Action on the grounds that the U.S. District Court for the
`
`District of New Jersey lacks personal jurisdiction over Teva USA. Teva USA further agrees that
`
`it will not contest venue in the District of New Jersey in the Action and, as such, will not move to
`
`transfer the venue of the Action. Teva USA further agrees that it will not assert any defense
`
`under Federal Rule of Civil Procedure 19 or otherwise assert that Teva Ltd. is a necessary party.
`
`6.
`
`Teva Ltd. submits and consents to the personal jurisdiction of the District of New
`
`Jersey solely for purposes of enforcing this Stipulation and Order and to adjudicate or resolve
`
`any disputes regarding its terms, interpretation, application, or requirements.
`
`7.
`
`The terms of this Stipulation and Order are without prejudice to any claims,
`
`defenses, or counterclaims that may be asserted in the Action, except with respect to the issues of
`
`personal jurisdiction, venue, and/or necessary parties addressed in Paragraphs 5 and 6 herein.
`
`8.
`
`The case caption should be amended to read as follows: “Celgene Corporation v.
`
`Par Pharmaceutical, Inc., Par Pharmaceutical Companies, Inc., and Teva Pharmaceuticals USA,
`
`Inc., Civil Action No. 17-3 159 (ES)(JAD),” as follows:
`
`Civil Action No. 17-3159 (ES)(JAD)
`
`CELGENE CORPORATION,
`
`Plaintiff,
`
`V.
`
`PAR PHARMACEUTICAL, INC., PAR
`PHARMACEUTICAL COMPANIES, INC.,
`and TEVA PHARMACEUTICALS USA,
`INC.,
`
`Defendants.
`
`3
`
`

`

`Case 2:17-cv-03159-ES-MAH Document 16 Filed 06/27/17 Page 4 of 4 PageID: 298
`
`Dated: June 22, 2017
`
`Charles M. Lizza
`William C. Baton
`SAuL EwiNG LLP
`One Riverfront Plaza, Suite 1520
`Newark, NJ 07 102-5426
`(973) 286-6700
`
`Attorneysfor Plaintiff
`Celgene Corporation
`
`SO
`
`RED:
`
`Jon. Esthe
`
`al
`
`, U.S.D.J.
`
`-
`
`Liza M. Walsh
`Christine I. Gannon
`WALSH Pizzi O’REILLY FALANGA LLP
`One Riverfront Plaza
`1037 Raymond Blvd., 6th Floor
`Newark, NJ 07102
`(973) 757-1100
`(973) 757-1090
`
`Attorneysfor Defendants
`Teva Pharmaceuticals USA, Inc. and
`Teva Pharmaceutical Industries Ltd.
`
`4
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket